Histopathologic evaluation of patients with liver-limited metastatic colorectal cancer receiving mFOLFOX6 plus bevacizumab or mFOLFOX6 plus cetuximab: The ATOM trial

Y. Emi, T. Yamanaka, K. Muro, H. Uetake, E. Oki, T. Takahashi, Y. Katayose, K. Yoshida, M. Sakamoto, S. Aishima, K. Ishida, J. Imura, M. Unno, I. Hyodo, N. Tomita, K. Sugihara, Y. Maehara

研究成果: Contribution to journalArticle査読

本文言語英語
ページ(範囲)viii164
ジャーナルAnnals of oncology : official journal of the European Society for Medical Oncology
29
DOI
出版ステータス出版済み - 10 1 2018

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

引用スタイル